Relating to: maintaining a supply of usable opioid antagonist at a public or private school and making an appropriation. (FE)

AB 1040 requires all public and private school boards, including charter schools, to maintain an easily accessible on-site supply of opioid antagonists (medication used to reverse opioid overdoses) at every school they oversee. It creates a grant program funded by a $100,000 appropriation increase for fiscal year 2026-27, allowing schools to purchase these antidotes to comply with the new requirement. The law takes effect on September 1, 2026, directly affecting school administrators and staff responsible for implementing this safety measure. This bill focuses on making life-saving medication readily available in schools without specifying outcomes or advocating for policy positions.